See the DrugPatentWatch profile for yervoy
Yervoy (Ipilimumab) Discount Promotion: Understanding the Timeline
The cost of cancer treatment can be a significant burden for patients and their families. To make these treatments more accessible, pharmaceutical companies often offer discount promotions and patient assistance programs. One such treatment is Yervoy (ipilimumab), a monoclonal antibody used to treat melanoma, a type of skin cancer. In this article, we'll explore the Yervoy discount promotion and when it's expected to end.
What is Yervoy?
Yervoy, also known as ipilimumab, is a medication used to treat melanoma, a type of skin cancer. It's a monoclonal antibody that works by enhancing the body's immune system to fight cancer cells. Yervoy was approved by the FDA in 2011 and has since become a standard treatment for patients with advanced melanoma.
Yervoy Discount Promotion
In 2019, Bristol-Myers Squibb, the manufacturer of Yervoy, launched a discount promotion program to make the treatment more affordable for patients. The program, which was initially set to expire in 2022, offers a discount of up to 80% off the list price of Yervoy.
How Does the Discount Promotion Work?
To be eligible for the Yervoy discount promotion, patients must meet certain criteria, including:
* Having a valid prescription for Yervoy
* Being a resident of the United States
* Having a household income at or below 500% of the federal poverty level
* Not being enrolled in any other patient assistance program for Yervoy
Patients who meet these criteria can apply for the discount promotion through the Bristol-Myers Squibb Patient Assistance Foundation website.
Timeline of the Yervoy Discount Promotion
The Yervoy discount promotion was initially set to expire in 2022, but it has been extended several times. According to the Bristol-Myers Squibb website, the discount promotion is currently set to expire on December 31, 2024.
Impact of the Discount Promotion
The Yervoy discount promotion has had a significant impact on patients with melanoma. By making the treatment more affordable, patients who may not have been able to access Yervoy otherwise have been able to receive the treatment they need.
Patient Assistance Programs
In addition to the discount promotion, Bristol-Myers Squibb offers several patient assistance programs to help patients access Yervoy. These programs include:
* The Bristol-Myers Squibb Patient Assistance Foundation: This program provides free or discounted Yervoy to eligible patients.
* The Copay Card Program: This program offers a copay card that can help patients pay for Yervoy.
* The Patient Access Network (PAN) Foundation: This program provides financial assistance to patients who are unable to afford Yervoy.
Conclusion
The Yervoy discount promotion has made a significant difference in the lives of patients with melanoma. By offering a discount of up to 80% off the list price of Yervoy, patients who may not have been able to access the treatment otherwise have been able to receive the care they need. While the discount promotion is set to expire on December 31, 2024, patients can still apply for the program through the Bristol-Myers Squibb Patient Assistance Foundation website.
Key Takeaways
* The Yervoy discount promotion offers a discount of up to 80% off the list price of Yervoy.
* The promotion is set to expire on December 31, 2024.
* Patients must meet certain criteria to be eligible for the discount promotion.
* Bristol-Myers Squibb offers several patient assistance programs to help patients access Yervoy.
Frequently Asked Questions
1. Q: What is the Yervoy discount promotion?
A: The Yervoy discount promotion is a program that offers a discount of up to 80% off the list price of Yervoy.
2. Q: How do I apply for the Yervoy discount promotion?
A: Patients can apply for the discount promotion through the Bristol-Myers Squibb Patient Assistance Foundation website.
3. Q: What are the eligibility criteria for the Yervoy discount promotion?
A: Patients must have a valid prescription for Yervoy, be a resident of the United States, have a household income at or below 500% of the federal poverty level, and not be enrolled in any other patient assistance program for Yervoy.
4. Q: What is the timeline for the Yervoy discount promotion?
A: The promotion is currently set to expire on December 31, 2024.
5. Q: What other patient assistance programs does Bristol-Myers Squibb offer?
A: Bristol-Myers Squibb offers several patient assistance programs, including the Bristol-Myers Squibb Patient Assistance Foundation, the Copay Card Program, and the Patient Access Network (PAN) Foundation.
Sources:
1. Bristol-Myers Squibb. (2022). Yervoy (Ipilimumab) Discount Promotion.
2. DrugPatentWatch.com. (2022). Yervoy (Ipilimumab) Patent Expiration.
3. National Cancer Institute. (2022). Ipilimumab.
4. FDA. (2022). Yervoy (Ipilimumab) Approval.
5. Bristol-Myers Squibb. (2022). Patient Assistance Programs.